65
Participants
Start Date
October 5, 2020
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Ketamine Hydrochloride
intravenous infusion
Esketamine
intravenous infusion
Placebo
intravenous infusion
Pilot study II: Esketamine
intravenous infusion
Pilot study II: Placebo
intravenous infusion
RECRUITING
Medical University of Vienna, Vienna
Medical University of Vienna
OTHER